Citigroup’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,122
| Closed | -$583K | – | 5858 |
|
|
2024
Q2 | $583K | Sell |
17,122
-173,223
| -91% | -$5.13M | ﹤0.01% | 3291 |
|
|
2024
Q1 | $6.7M | Buy |
190,345
+103,012
| +118% | +$3.45M | ﹤0.01% | 1515 |
|
|
2023
Q4 | $2.52M | Buy |
87,333
+27,217
| +45% | +$648K | ﹤0.01% | 2046 |
|
|
2023
Q3 | $1.38M | Buy |
60,116
+13,386
| +29% | +$702K | ﹤0.01% | 2273 |
|
|
2023
Q2 | $2.68M | Sell |
46,730
-938
| -2% | -$49K | ﹤0.01% | 1950 |
|
|
2023
Q1 | $1.79M | Sell |
47,668
-936
| -2% | -$34.5K | ﹤0.01% | 2098 |
|
|
2022
Q4 | $1.3M | Sell |
48,604
-37,683
| -44% | -$1.03M | ﹤0.01% | 2382 |
|
|
2022
Q3 | $2.44M | Buy |
86,287
+3,225
| +4% | +$89.9K | ﹤0.01% | 2007 |
|
|
2022
Q2 | $1.8M | Buy |
83,062
+70,732
| +574% | +$1.97M | ﹤0.01% | 2182 |
|
|
2022
Q1 | $495K | Sell |
12,330
-34,687
| -74% | -$1.45M | ﹤0.01% | 3512 |
|
|
2021
Q4 | $2.23M | Buy |
47,017
+26,254
| +126% | +$1.41M | ﹤0.01% | 2541 |
|
|
2021
Q3 | $1.18M | Sell |
20,763
-27,969
| -57% | -$1.69M | ﹤0.01% | 2964 |
|
|
2021
Q2 | $2.8M | Buy |
48,732
+47,682
| +4,541% | +$2.62M | ﹤0.01% | 2395 |
|
|
2021
Q1 | $66K | Sell |
1,050
-1,766
| -63% | -$81.1K | ﹤0.01% | 4561 |
|
|
2020
Q4 | $94K | Buy |
2,816
+2,157
| +327% | +$63.7K | ﹤0.01% | 5581 |
|
|
2020
Q3 | $18K | Sell |
659
-1,196
| -64% | -$31.4K | ﹤0.01% | 6281 |
|
|
2020
Q2 | $50K | Sell |
1,855
-1,227
| -40% | -$23K | ﹤0.01% | 6021 |
|
|
2020
Q1 | $45K | Buy |
3,082
+2,089
| +210% | +$35K | ﹤0.01% | 6061 |
|
|
2019
Q4 | $17K | Buy |
993
+773
| +351% | +$12.1K | ﹤0.01% | 7006 |
|
|
2019
Q3 | $4K | Buy |
+220
| New | +$4.61K | ﹤0.01% | 7411 |
|
Other funds holding MORF
Citigroup's MORF Position: Q3 2024 in Review
Citigroup sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 17,122 shares — an estimated $583K sold.
Citigroup first reported a position in MORF in Q3 2019 and held it in 20 quarters. The position peaked at $6.7M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- Citigroup reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Citigroup sold 17,122 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $583K.
- Citigroup first reported a position in Morphic Holding, Inc. Common Stock in Q3 2019 and held it in 20 quarters.
- Citigroup's Morphic Holding, Inc. Common Stock position peaked at $6.7M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.